Neglected Disease R&D On The Rise, But Funding Gaps Remain
This article was originally published in PharmAsia News
A year after the broad London Declaration on Neglected Tropical Diseases, R&D projects for tropical diseases are up more than 40%.
You may also be interested in...
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.
Some health-focused Millennium Development Goals are likely to fail to reach a successful benchmark by 2015. Companies are exploring new partnership models for public health achievements.